AR074048A1 - Solucion a base de urea formadora de pelicula para el tratamiento de la psoriasis de las unas - Google Patents
Solucion a base de urea formadora de pelicula para el tratamiento de la psoriasis de las unasInfo
- Publication number
- AR074048A1 AR074048A1 ARP090104037A AR074048A1 AR 074048 A1 AR074048 A1 AR 074048A1 AR P090104037 A ARP090104037 A AR P090104037A AR 074048 A1 AR074048 A1 AR 074048A1
- Authority
- AR
- Argentina
- Prior art keywords
- psoriasis
- unas
- film
- treatment
- based solution
- Prior art date
Links
- 201000004681 Psoriasis Diseases 0.000 title abstract 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 title abstract 2
- 239000004202 carbamide Substances 0.000 title abstract 2
- DOIRQSBPFJWKBE-UHFFFAOYSA-N dibutyl phthalate Chemical compound CCCCOC(=O)C1=CC=CC=C1C(=O)OCCCC DOIRQSBPFJWKBE-UHFFFAOYSA-N 0.000 abstract 2
- FLKPEMZONWLCSK-UHFFFAOYSA-N diethyl phthalate Chemical compound CCOC(=O)C1=CC=CC=C1C(=O)OCC FLKPEMZONWLCSK-UHFFFAOYSA-N 0.000 abstract 2
- PYGXAGIECVVIOZ-UHFFFAOYSA-N Dibutyl decanedioate Chemical compound CCCCOC(=O)CCCCCCCCC(=O)OCCCC PYGXAGIECVVIOZ-UHFFFAOYSA-N 0.000 abstract 1
- 241000233866 Fungi Species 0.000 abstract 1
- DOOTYTYQINUNNV-UHFFFAOYSA-N Triethyl citrate Chemical compound CCOC(=O)CC(O)(C(=O)OCC)CC(=O)OCC DOOTYTYQINUNNV-UHFFFAOYSA-N 0.000 abstract 1
- 239000006184 cosolvent Substances 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- KSCKTBJJRVPGKM-UHFFFAOYSA-N octan-1-olate;titanium(4+) Chemical compound [Ti+4].CCCCCCCC[O-].CCCCCCCC[O-].CCCCCCCC[O-].CCCCCCCC[O-] KSCKTBJJRVPGKM-UHFFFAOYSA-N 0.000 abstract 1
- 239000004014 plasticizer Substances 0.000 abstract 1
- 239000002798 polar solvent Substances 0.000 abstract 1
- 229920001223 polyethylene glycol Polymers 0.000 abstract 1
- 229920000642 polymer Polymers 0.000 abstract 1
- WEAPVABOECTMGR-UHFFFAOYSA-N triethyl 2-acetyloxypropane-1,2,3-tricarboxylate Chemical compound CCOC(=O)CC(C(=O)OCC)(OC(C)=O)CC(=O)OCC WEAPVABOECTMGR-UHFFFAOYSA-N 0.000 abstract 1
- VMYFZRTXGLUXMZ-UHFFFAOYSA-N triethyl citrate Natural products CCOC(=O)C(O)(C(=O)OCC)C(=O)OCC VMYFZRTXGLUXMZ-UHFFFAOYSA-N 0.000 abstract 1
- 235000013769 triethyl citrate Nutrition 0.000 abstract 1
- 239000001069 triethyl citrate Substances 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Manufacture Of Macromolecular Shaped Articles (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0857146A FR2937250B1 (fr) | 2008-10-21 | 2008-10-21 | Solution filmogene a base d'uree pour le traitement du psorasis de l'ongle |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR074048A1 true AR074048A1 (es) | 2010-12-22 |
Family
ID=40823172
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP090104037 AR074048A1 (es) | 2008-10-21 | 2009-10-21 | Solucion a base de urea formadora de pelicula para el tratamiento de la psoriasis de las unas |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US20110200544A1 (https=) |
| EP (1) | EP2349243B1 (https=) |
| JP (1) | JP2012506372A (https=) |
| KR (1) | KR20110071118A (https=) |
| CN (1) | CN102186468B (https=) |
| AR (1) | AR074048A1 (https=) |
| AU (1) | AU2009306462B2 (https=) |
| BR (1) | BRPI0919833A2 (https=) |
| CA (1) | CA2740001A1 (https=) |
| ES (1) | ES2560178T3 (https=) |
| FR (1) | FR2937250B1 (https=) |
| GE (1) | GEP20135746B (https=) |
| IL (1) | IL212372A0 (https=) |
| MA (1) | MA32800B1 (https=) |
| MX (1) | MX2011004016A (https=) |
| NZ (1) | NZ592733A (https=) |
| PL (1) | PL2349243T3 (https=) |
| PT (1) | PT2349243E (https=) |
| RU (1) | RU2508090C2 (https=) |
| TN (1) | TN2011000167A1 (https=) |
| UA (1) | UA102705C2 (https=) |
| WO (1) | WO2010046375A1 (https=) |
| ZA (1) | ZA201103437B (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5840437B2 (ja) * | 2011-09-30 | 2016-01-06 | 日本メナード化粧品株式会社 | 抗炎症剤 |
| US20140271529A1 (en) * | 2013-03-14 | 2014-09-18 | Alc Therapeutics, Llc | Antifungal compositions for the treatment of secondary skin and nail infections |
| CN104758273B (zh) * | 2015-04-09 | 2018-04-20 | 山东罗欣药业集团股份有限公司 | 一种尿素微囊制剂及其制备方法 |
| US20220249859A1 (en) * | 2021-02-09 | 2022-08-11 | Scholl's Wellness Company Llc | Formulation and device for cosmetic treatment of onychomycosis |
| WO2026046372A1 (en) * | 2024-08-30 | 2026-03-05 | Shenzhen Pharmacin Co., Ltd. | Compositions for nail conditions and uses thereof |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2613227B1 (fr) * | 1987-04-01 | 1990-12-28 | Oreal | Compositions pharmaceutiques a base de nitrate de miconazole ou de nitrate d'econazole dans le traitement des infections fongiques des ongles |
| DE4212105A1 (de) * | 1992-04-10 | 1993-10-14 | Roehm Pharma Gmbh | Nagellack zur Behandlung von Onychomykosen |
| RO118174B1 (ro) * | 1997-08-21 | 2003-03-28 | Aventis Pharma Deutschland Gmbh | Lac de unghii şi utilizarea acestuia |
| ES2260093T3 (es) * | 2000-01-03 | 2006-11-01 | Karl Kraemer | Preparados para la eliminacion ungueal atraumatica. |
| US7074392B1 (en) * | 2000-03-27 | 2006-07-11 | Taro Pharmaceutical Industries Limited | Controllled delivery system of antifungal and keratolytic agents for local treatment of fungal infections |
| US6281239B1 (en) * | 2000-04-12 | 2001-08-28 | Bradley Pharmeaceuticals, Inc. | Method of treating onychomycosis |
| HUP0501023A3 (en) * | 2001-01-09 | 2008-04-28 | Dvoretzky | Therapeutic film forming composition and treatment system therefor |
| DE10126501A1 (de) * | 2001-05-30 | 2002-12-12 | Aventis Pharma Gmbh | Zubereitung zur Entfernung von abnormen Keratinmaterial |
| US6821508B2 (en) * | 2001-06-27 | 2004-11-23 | Rutgers, The State University | Composition and method for topical nail treatment |
| CZ2004316A3 (cs) * | 2001-09-04 | 2004-10-13 | Trommsdorffágmbhá@Áco@Ákgáarzneimittel | Náplast |
| US20040071760A1 (en) * | 2002-01-07 | 2004-04-15 | Israel Dvoretzky | Therapeutic film forming composition and treatment system therefor |
| MXPA05002065A (es) * | 2002-09-05 | 2005-06-08 | Galderma Sa | Solucion para aplicacion ungueal. |
| CN1215838C (zh) * | 2003-06-25 | 2005-08-24 | 蚌埠丰原医药科技发展有限公司 | 双氯芬酸钠贴剂及其制备方法 |
| EP1648378A2 (fr) * | 2003-07-29 | 2006-04-26 | Pierre Fabre Dermo-Cosmetique | Vernis a ongles a action antimycosique |
| DE10341944A1 (de) * | 2003-09-11 | 2005-04-28 | York Pharma Plc | Antimykotisch wirksame Nagellackformulierung mit substituierten 2-Aminothiazolen als Wirkstoff |
-
2008
- 2008-10-21 FR FR0857146A patent/FR2937250B1/fr active Active
-
2009
- 2009-10-21 AR ARP090104037 patent/AR074048A1/es not_active Application Discontinuation
- 2009-10-21 WO PCT/EP2009/063771 patent/WO2010046375A1/en not_active Ceased
- 2009-10-21 CN CN200980141638.4A patent/CN102186468B/zh not_active Expired - Fee Related
- 2009-10-21 KR KR20117011030A patent/KR20110071118A/ko not_active Ceased
- 2009-10-21 CA CA 2740001 patent/CA2740001A1/en not_active Abandoned
- 2009-10-21 RU RU2011119924/15A patent/RU2508090C2/ru not_active IP Right Cessation
- 2009-10-21 ES ES09759912.0T patent/ES2560178T3/es active Active
- 2009-10-21 MX MX2011004016A patent/MX2011004016A/es active IP Right Grant
- 2009-10-21 UA UAA201106327A patent/UA102705C2/ru unknown
- 2009-10-21 NZ NZ592733A patent/NZ592733A/en not_active IP Right Cessation
- 2009-10-21 US US13/124,796 patent/US20110200544A1/en not_active Abandoned
- 2009-10-21 EP EP09759912.0A patent/EP2349243B1/en active Active
- 2009-10-21 GE GEAP2009012228 patent/GEP20135746B/en unknown
- 2009-10-21 BR BRPI0919833A patent/BRPI0919833A2/pt not_active IP Right Cessation
- 2009-10-21 PL PL09759912T patent/PL2349243T3/pl unknown
- 2009-10-21 JP JP2011531517A patent/JP2012506372A/ja active Pending
- 2009-10-21 AU AU2009306462A patent/AU2009306462B2/en not_active Ceased
- 2009-10-21 PT PT97599120T patent/PT2349243E/pt unknown
-
2011
- 2011-04-08 TN TN2011000167A patent/TN2011000167A1/fr unknown
- 2011-04-14 IL IL212372A patent/IL212372A0/en unknown
- 2011-05-11 ZA ZA2011/03437A patent/ZA201103437B/en unknown
- 2011-05-17 MA MA33852A patent/MA32800B1/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PT2349243E (pt) | 2016-03-14 |
| GEP20135746B (en) | 2013-02-11 |
| FR2937250B1 (fr) | 2013-05-10 |
| CN102186468B (zh) | 2014-02-12 |
| RU2508090C2 (ru) | 2014-02-27 |
| KR20110071118A (ko) | 2011-06-28 |
| BRPI0919833A2 (pt) | 2015-12-15 |
| FR2937250A1 (fr) | 2010-04-23 |
| HK1156532A1 (en) | 2012-06-15 |
| AU2009306462B2 (en) | 2013-08-22 |
| PL2349243T3 (pl) | 2016-07-29 |
| EP2349243B1 (en) | 2015-11-11 |
| AU2009306462A1 (en) | 2010-04-29 |
| TN2011000167A1 (en) | 2012-12-17 |
| MA32800B1 (fr) | 2011-11-01 |
| RU2011119924A (ru) | 2012-11-27 |
| US20110200544A1 (en) | 2011-08-18 |
| CN102186468A (zh) | 2011-09-14 |
| NZ592733A (en) | 2012-03-30 |
| IL212372A0 (en) | 2011-06-30 |
| CA2740001A1 (en) | 2010-04-29 |
| WO2010046375A1 (en) | 2010-04-29 |
| MX2011004016A (es) | 2011-05-19 |
| EP2349243A1 (en) | 2011-08-03 |
| UA102705C2 (ru) | 2013-08-12 |
| ES2560178T3 (es) | 2016-02-17 |
| ZA201103437B (en) | 2012-01-25 |
| JP2012506372A (ja) | 2012-03-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1125193T1 (el) | Φαρμακευτικες συνθεσεις που περιλαμβανουν μελοξικαμη | |
| CY1121694T1 (el) | Ενωσεις δι-κυκλικου-συντηγμενου ετεροαρυλιου ή αρυλιου και η χρηση αυτων ως αναστολεις irak4 | |
| JOP20190174A1 (ar) | مثبطات jak1 انتقائية | |
| WO2016011390A8 (en) | Irak4 inhibiting agents | |
| FI3618875T3 (fi) | Raf-inhibiittoria ja trametinibia käsittävä yhdistelmähoito | |
| CL2018000706A1 (es) | Derivados de pirazolopirimidina como inhibidores btk para el tratamiento del cancer. | |
| CO2020013840A2 (es) | Benzofurano, benzopirrol, benzotiofeno sustituidos y otros inhibidores del complemento estructuralmente relacionados | |
| MX388538B (es) | Derivados de pirano como inhibidores de cyp11a1 (citocromo p450 monooxigenasa 11a1). | |
| MX2016001480A (es) | Formulacion de inhibidores de syk. | |
| WO2016065245A8 (en) | Extra luminal scaffold | |
| CR20140231A (es) | Derivados de ácido benzotiazol-6-il acético y su uso para tratar una infección por vih | |
| CR20120418A (es) | Inhibidores de virus flaviviridae | |
| AR074048A1 (es) | Solucion a base de urea formadora de pelicula para el tratamiento de la psoriasis de las unas | |
| GEAP201914546A (en) | 5-[(piperazin-1-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as adamts inhibitors for the treatment of osteoarthritis | |
| BR112017000730A2 (pt) | derivados de pirrolidinona como inibidores de metap-2 | |
| UY36761A (es) | Formulación oral sólida que contiene irinotecán y método 20 de preparación de la misma | |
| CO2017008080A2 (es) | Métodos para modificar la reología de los polímeros | |
| FI3248597T3 (fi) | Terapeuttinen aine sensorineuraaliseen kuulonmenetykseen | |
| MX380865B (es) | COMPUESTOS DERIVADOS DE 1,6-DIAZABICICLO [3.2.1]OCT-3-EN-6-IL COMO INHIBIDORES DE LA ß-LACTAMASA, Y EL USO DE LOS MISMOS EN EL TRATAMIENTO DE INFECCIONES BACTERIANAS. | |
| MX2019001225A (es) | Compuesto aromatico heterociclico nitrogenoso, metodo de preparacion del mismo, composicion farmaceutico del mismo y aplicacion del mismo. | |
| CL2016002318A1 (es) | Composición farmacéutica en forma de solución que comprende un portador líquido que comprende agua y entre 20% y 95% de uno o mas alcoholes y citrato de sildenafil disuelto en dicho portador líquido a una concentración de entre 7 y 125 mg/ml; métodos para obtenerla; forma de dosificación oral; forma de dosificación bucal; kits. | |
| MX2015005837A (es) | Composicion de enema para el tratamiento de colitis ulcerosa que tiene estabilidad a largo plazo. | |
| ECSP18000689A (es) | Composiciones farmacéuticas sólidas para el tratamiento del vhc | |
| MY184693A (en) | Bilayer hydrocolloid films containing therapeutic agents | |
| AR086876A1 (es) | Derivados heterociclicos de sulfonamida |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |